This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pregnant patients with Type 2 Diabetes. 40 participants will be on study for approximately 182 days (26 weeks).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility: Number of Participants Who Complete the Study Within 24 Month Time Period
Timeframe: up to 24 months
Change in Qualitative Survey Answers to Assess Participant Thoughts and Experiences With Diabetes Management
Timeframe: baseline, 12 weeks on study, and postpartum (up to 26 weeks on study)
Percentage of Time Where Blood Glucose is Between 70-140 Milligrams Per Deciliter (mg/dL) - Time in Range
Timeframe: Baseline, 26 weeks